Do We Still Need Pioglitazone for The Management of Type 2 Diabetes Mellitus? A Peep In To Risk of Bladder Cancer in Diabetic Population
Journal Title: Journal of Endocrinology and Diabetes - Year 2018, Vol 5, Issue 2
Abstract
Pioglitazone use and risk of bladder cancer in diabetic patient one of the major cause of morbidity and mortality. Increasing evidence from the clinical studies suggested increased risk of bladder cancer with higher dose and longer duration of pioglitazone use. In contrast, few studies reported non-significant association with pioglitazone use and risk of bladder cancer in T2DM patients. Therefore, we aimed to review and summarize the available clinical data describing the risk of bladder cancer associated with pioglitazone treatment.
Authors and Affiliations
Manju Sharma, Azharuddin n, Tarique Faheem, Mohammad Adil, Pinaki Ghosh
Sex-Differences of Low to Moderate Leisure-Time Physical Activity on Metabolic Risk Factors in Type 2 Diabetes Mellitus Patients
Background: Exercise is an integral part of the diabetes management and prevention. However, it is hard to maintain and to reach current recommendation due to the unavoidable aging process. This cross-sectional study inv...
Diabetes Autoantibodies Mediate Neural- and Endothelial Cell- Inhibitory Effects Via 5-Hydroxytryptamine- 2 Receptor Coupled to Phospholipase C/Inositol Triphosphate/Ca2+ Pathway
Aims: To identify the G-protein coupled receptor(s) on neuroblastoma and endothelial cells which mediate neural- and endothelial cellinhibitory effects in plasma autoantibodies from a subset of older type 2 diabetes with...
Normocalcemic Primary Hyperparathyroidism
The prevalence and the natural history of Normocalcemic Primary Hyperparathyroidism (NCHPT) are not well known. Therefore the aim of this retrospective study was to determine the prevalence and natural history of (NCHPT)...
Surgery in Refractory Amiodarone-Induced Thyrotoxicosis
Background: Thyroidectomy is a challenging treatment for refractory amiodarone induced thyrotoxicosis (AIT). Objectives: The authors’ aim in this article is to conduct a systematic review of the currently available lite...
Circulating Neurotoxic 5-HT2A Receptor Agonist Autoantibodies in Adult Type 2 Diabetes with Parkinson’s Disease
ims: To test whether circulating neurotoxic autoantibodies increase in adult type 2 diabetes mellitus with Parkinson’s disease (PD) or dementia. To identify the G-protein coupled receptor on neuroblastoma cells mediating...